Skip to main content
July 1, 2022
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Home
Ovarian Cancer
Ovarian Cancer Overviews
Ovarian Cancer Survivorship
Ovarian Cancer Treatment
Ovarian Cancer Treatment
Ovarian Cancer Treatment
Ovarian Cancer Treatment
Farletuzumab Promise in Relapsed Ovarian Cancer?
By CancerConnect
Jun 6, 2022
Ovarian Cancer Treatment
Rubraca Significantly Improves Ovarian Cancer Treatment
By Dr. C.H. Weaver M.D.
Apr 1, 2022
Ovarian Cancer Treatment
The Antibody Drug Conjugate Mirvetuximab soravtansine appears promising for treatment of certain patients with ovarian cancer.
By Dr. C.H. Weaver M.D.
Mar 24, 2022
Ovarian Cancer Treatment
Mekinist for Low Grade Ovarian Cancer
By Dr. C.H. Weaver M.D.
Feb 6, 2022
Ovarian Cancer Treatment
Zejula (Niraparib) Improves Progression-Free Survival in Ovarian Cancer
By Dr. C.H. Weaver M.D.
Jan 18, 2022
Ovarian Cancer Treatment
Lynparza Delays Progression & Significantly Prolongs Survival in Ovarian Cancer
By Dr. C.H. Weaver M.D.
Nov 19, 2021
Ovarian Cancer Treatment
Update on PARP Inhibitors & Other Precision Cancer Medicines for Ovarian Cancer
By Dr. C.H. Weaver M.D.
Sep 30, 2021
Ovarian Cancer Treatment
Precision Antibody-drug conjugate promising in Ovarian Cancer
By Dr. C.H. Weaver M.D.
Sep 23, 2021
Ovarian Cancer Treatment
The CA 125 “tumor associated protein” or “tumor marker”
By MedMaven
Jul 23, 2021
Ovarian Cancer Treatment
Precision Cancer Medicines for Ovarian Cancer
By Dr. C.H. Weaver M.D.
Jul 3, 2021
Ovarian Cancer Treatment
Berzosertib - A Novel ATR Inhibitor in Development
By Dr. C.H. Weaver M.D.
Jun 29, 2021
Ovarian Cancer Treatment
Investigational Vaccine to be Tested in Ovarian Cancer
By CancerConnect
Dec 22, 2020
Ovarian Cancer Treatment
XMT-1536 in Ovarian Cancer
By MedMaven
Aug 26, 2020
Ovarian Cancer Treatment
Ofranergene obadenovec (VB-111) in Ovarian Cancer
By MedMaven
Aug 26, 2020
Ovarian Cancer Treatment
September Is National Ovarian Cancer Awareness Month
By CancerConnect
Aug 23, 2020
Ovarian Cancer Treatment
Immunotherapy in Ovarian Cancer Treatment: Is More Better, or Just More?
By MedMaven
Jul 16, 2020
Ovarian Cancer Treatment
Gemzar® Plus Doxil® for Recurrent Ovarian Cancer
By CancerConnect
Jun 30, 2020
Ovarian Cancer Treatment
Is Secondary Cytoreduction in Recurrent Ovarian Cancer Necessary?
By MedMaven
Jun 20, 2020
Ovarian Cancer Treatment
The Addition of CTLA4 to PD-1 Precision Therapy Could Benefit Women with Ovarian
By MedMaven
Jan 20, 2020
Ovarian Cancer Treatment
Opdivo - Avastin for Recurrent Ovarian Cancer
By MedMaven
Dec 30, 2019
Ovarian Cancer Treatment
Sitravatinib and Tislelizumab for Resistant Ovarian Cancer
By MedMaven
Dec 14, 2019
Ovarian Cancer Treatment
Votrient Maintenance Therapy in Ovarian Cancer
By CancerConnect
Dec 3, 2019
Ovarian Cancer Treatment
Qualifying for Social Security Benefits for Ovarian Cancer
By MedMaven
Sep 10, 2019
Ovarian Cancer Treatment
PARP – Checkpoint Inhibitor Combo Promising in Ovarian Cancer
By CancerConnect
Jul 5, 2019
Ovarian Cancer Treatment
Lynparza – Alpelisib Combo Therapy Shows Promise in Epithelial Ovarian Cancer
By MedMaven
Apr 2, 2019
Ovarian Cancer Treatment
Novel Vaccine May Represent New Treatment Option for Ovarian Cancer
By MedMaven
Mar 21, 2019
Ovarian Cancer Treatment
The CancerConnect Ovarian Cancer Newsletter
By TraceyS
Feb 5, 2019
Ovarian Cancer Treatment
Treatment at High-Volume Hospitals Reduces Mortality Rates for Ovarian Patients
By CancerConnect
Dec 13, 2018
Ovarian Cancer Treatment
About The National Ovarian Cancer Coalition
By CancerConnect
Sep 14, 2018
Ovarian Cancer Treatment
AFCR Scientists Uncovered Potential New Treatment for Ovarian Cancer
By CancerConnect
Aug 27, 2018
Ovarian Cancer Treatment
Dose-Dense Paclitaxel Plus Carboplatin Improves Long-Term Survival
By CancerConnect
Aug 27, 2018
Ovarian Cancer Treatment
Ovarian Cancer Clinical Trials: What, Where, Why
By CancerConnect
Aug 23, 2018
Ovarian Cancer Treatment
Roswell Park Cancer Institute Experts Discuss Ovarian Cancer Research
By CancerConnect
Aug 22, 2018
Ovarian Cancer Treatment
Vaccines Stimulating Immune System Produce Responses in Advanced Ovarian Cancers
By CancerConnect
Aug 17, 2018
Ovarian Cancer Treatment
T-Cells Can be Directed to Treat a Variety of Ovarian Cancers
By CancerConnect
Aug 17, 2018
Ovarian Cancer Treatment
SGO, ASCO Issue New Guidelines for Ovarian Cancer Treatment
By CancerConnect
Aug 17, 2018
Ovarian Cancer Treatment
Dacogen Helps Recurrent Ovarian Cancer Respond to Vaccine
By CancerConnect
Aug 16, 2018
Ovarian Cancer Treatment
FDA Approves Avastin® Plus Chemotherapy for Treatment of Advanced Ovarian Cancer
By CancerConnect
Aug 15, 2018
Ovarian Cancer Treatment
Avastin Plus Chemotherapy Improves Progression-Free Survival in Ovarian Cancer
By CancerConnect
Aug 13, 2018
Ovarian Cancer Treatment
Intraperitoneal Chemotherapy Underused in Ovarian Cancer
By CancerConnect
Aug 12, 2018
Ovarian Cancer Treatment
Summary News on Melanoma, Breast, Cervical, Ovarian, Prostate & Thyroid Cancer
By CancerConnect
Aug 10, 2018
Ovarian Cancer Treatment
Delaying Therapy Increases Mortality in Ovarian Cancer
By CancerConnect
Aug 10, 2018
Ovarian Cancer Treatment
Novel Two-step Immunotherapy Shows Promise in Recurrent Ovarian Cancer
By CancerConnect
Aug 10, 2018
Ovarian Cancer Treatment
Cediranib Combined with Olaparib in Ovarian Cancer
By CancerConnect
Aug 10, 2018
Ovarian Cancer Treatment
Dr. Chi and Dr. Bell-McGuinn Discuss Treatment Options for Ovarian Cancer
By CancerConnect
Aug 9, 2018
Ovarian Cancer Treatment
Smoking Increases Risk of Mucinous Ovarian Cancer
By CancerConnect
Aug 6, 2018
Ovarian Cancer Treatment
National Ovarian Cancer Coalition Launches CancerConnect Social Media Platform
By CancerConnect
Aug 3, 2018
Ovarian Cancer Treatment
Eye on the Prize
By CancerConnect
Aug 2, 2018
Ovarian Cancer Treatment
Avastin Delays Progression of Ovarian Cancer But May Not Improve Survival
By CancerConnect
Aug 2, 2018
Ovarian Cancer Treatment
Forging Ahead: Advances in the Fight Against Ovarian Cancer
By CancerConnect
Aug 1, 2018
CLOSE
CLOSE
CLOSE
CLOSE
